Astellas Pharma Inc. Chief Commercial Officer Claus Zieler has named Michael Petroutsas as Head, United States Commercial, leading the Astellas Pharma US Inc. organization. Petroutsas will be responsible for the company's US commercial operations.
Petroutsas will succeed Mark Reisenauer, who is leaving Astellas at the end of March.
"With more than 25 years of experience in the pharmaceutical industry, Mike has effectively led extensive global commercial, strategic, and operational teams. Mike exemplifies leadership through his consistent delivery of high performance. I am assured that his commitment and dedication will empower Astellas in the US, our biggest market globally, to provide the utmost value for patients," said Claus Zieler, Chief Commercial Officer.
"I am inspired by Astellas' mission and strong reputation to deliver ground-breaking, innovative medicines that can transform the lives of patients with the highest need," said Petroutsas. "I'm committed to putting patients first to create healthcare solutions that matter and excited to begin this next chapter in delivering on the full potential of the Astellas medicines."
Prior to Astellas, Petroutsas served as Senior Vice President, US Specialty and Oncology Business, at GSK. There he successfully launched the US Oncology division and focused on commercializing transformational medicines to help many patients with complex diseases in immunology, hepatology, respiratory and renal areas. Before that, he held senior positions at Pfizer and Novartis Oncology.
Subscribe to our e-Newsletters
Stay up to date with the latest news, articles, and events. Plus, get special offers
from American Pharmaceutical Review – all delivered right to your inbox!
Sign up now!